Teresa Yu Ping Lim, Zhen Xuan Wong, Benedict Jin Kiat Bay, Darryl Heng Yik Ooi, Christophe Sandt, Ricky Yu-Syun Fan, Yongxin Li, Kien Voon Kong, Helene C Bertrand, Weng Kee Leong
A central issue with the use of transition metal carbonyl complexes in CO-release medical therapy centers around the attendant side effects associated with the products after CO release (iCORMs). In this study, we examined the feasibility of an organometallic-nanoparticle (AuNP@OM) construct as a means to stabilize the iCORM of a photoactivable CO-releasing molecule (photoCORM), as well as for tracking. Four metal carbonyl complexes comprising a group 7 or 8 metal and bearing the 3-di(pyridin-2-yl)benzo[g]quinoxaline (dpb) ligand were assessed, along with their AuNP@OM constructs, for such use.
{"title":"Organometallic-Nanoparticle Constructs as CO-Release Theranostics: An Evaluation with Some Group 7 and 8 Metals.","authors":"Teresa Yu Ping Lim, Zhen Xuan Wong, Benedict Jin Kiat Bay, Darryl Heng Yik Ooi, Christophe Sandt, Ricky Yu-Syun Fan, Yongxin Li, Kien Voon Kong, Helene C Bertrand, Weng Kee Leong","doi":"10.1021/acsabm.6c01529","DOIUrl":"https://doi.org/10.1021/acsabm.6c01529","url":null,"abstract":"<p><p>A central issue with the use of transition metal carbonyl complexes in CO-release medical therapy centers around the attendant side effects associated with the products after CO release (iCORMs). In this study, we examined the feasibility of an organometallic-nanoparticle (AuNP@OM) construct as a means to stabilize the iCORM of a photoactivable CO-releasing molecule (photoCORM), as well as for tracking. Four metal carbonyl complexes comprising a group 7 or 8 metal and bearing the 3-di(pyridin-2-yl)benzo[g]quinoxaline (dpb) ligand were assessed, along with their AuNP@OM constructs, for such use.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149392114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Francesco Cardoni, Stefano Casalini, Davide Ferraro, Manuel María Mazo Vega, Stefano Bonaldo, Dorleta Jimenez de Aberasturi, Lucio Litti
The development of sustainable microelectronic fabrication strategies is increasingly important due to the environmental and economic limitations of conventional photolithography and vacuum-based metal deposition processes. These approaches typically require hazardous chemicals and high energy consumption. In this work, we address these challenges by introducing an environmental friendly fabrication route for patterning gold microelectrodes, based on inkjet-printed dextran sacrificial masks and spray-coated gold nanoparticles (AuNPs) synthesized via pulsed laser ablation. Inkjet printing enables maskless and material-efficient patterning, while spray coating provides a low-temperature and scalable route for the deposition of conductive nanoparticle networks. The resulting microelectrodes exhibit excellent electrical conductivity (sheet resistance of 37.01 ± 12.09 Ω/square and conductivity of 0.0037 ± 0.0008 MS/cm) and well-defined interdigitated geometries suitable for bioelectronic applications. To evaluate their performance, human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are cultured directly on the electrodes. Electrochemical impedance spectroscopy (EIS) is employed as a label-free and real-time technique to monitor cell-electrode interactions and temporal variations in cell coverage and viability. EIS measurements, supported by equivalent circuit modeling, reveal distinct phases corresponding to initial cell adhesion, progressive remodeling of the cellular layer, and long-term reduction in viability, further validated by optical measurements. Overall, this work demonstrates a sustainable and cost-effective fabrication strategy for gold microelectrodes, enabling quantitative, noninvasive monitoring of cellular dynamics through impedance-derived parameters and image-based validation of cell coverage evolution.
{"title":"Sustainable Microelectrode Fabrication for Electrochemical Impedance-Based In Situ Monitoring In Vitro Models.","authors":"Francesco Cardoni, Stefano Casalini, Davide Ferraro, Manuel María Mazo Vega, Stefano Bonaldo, Dorleta Jimenez de Aberasturi, Lucio Litti","doi":"10.1021/acsabm.6c01643","DOIUrl":"https://doi.org/10.1021/acsabm.6c01643","url":null,"abstract":"<p><p>The development of sustainable microelectronic fabrication strategies is increasingly important due to the environmental and economic limitations of conventional photolithography and vacuum-based metal deposition processes. These approaches typically require hazardous chemicals and high energy consumption. In this work, we address these challenges by introducing an environmental friendly fabrication route for patterning gold microelectrodes, based on inkjet-printed dextran sacrificial masks and spray-coated gold nanoparticles (AuNPs) synthesized via pulsed laser ablation. Inkjet printing enables maskless and material-efficient patterning, while spray coating provides a low-temperature and scalable route for the deposition of conductive nanoparticle networks. The resulting microelectrodes exhibit excellent electrical conductivity (sheet resistance of 37.01 ± 12.09 Ω/square and conductivity of 0.0037 ± 0.0008 MS/cm) and well-defined interdigitated geometries suitable for bioelectronic applications. To evaluate their performance, human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are cultured directly on the electrodes. Electrochemical impedance spectroscopy (EIS) is employed as a label-free and real-time technique to monitor cell-electrode interactions and temporal variations in cell coverage and viability. EIS measurements, supported by equivalent circuit modeling, reveal distinct phases corresponding to initial cell adhesion, progressive remodeling of the cellular layer, and long-term reduction in viability, further validated by optical measurements. Overall, this work demonstrates a sustainable and cost-effective fabrication strategy for gold microelectrodes, enabling quantitative, noninvasive monitoring of cellular dynamics through impedance-derived parameters and image-based validation of cell coverage evolution.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149384731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Orthopedic implants can become infected in hospitals requiring additional surgeries and device replacement. The pathogenesis of these device-associated bone infections is fundamentally driven by the transition of opportunistic pathogens from a free-floating planktonic state to a surface-bound, highly resilient biofilm state. Biofilms shield resident bacteria within a self-secreted extracellular polymeric substance (EPS) matrix, making them up to 1000-fold more resistant to conventional systemic antibiotics and host-immune clearance. To overcome the clinical challenges of biofilm elimination, the field of regenerative bone biointerfaces is transitioning from traditional antibiotic therapies toward multifunctional, fully resorbable, dual-therapy biomaterial platforms. These modern architectures are engineered to simultaneously clear localized infections and orchestrate host bone tissue reconstruction within a single surgical window. This review provides a comprehensive categorization and critical evaluation of six breakthrough therapeutic themes shaping next-generation orthopedic scaffolds: (1) spatiotemporally optimized dual or multiple antibiotic delivery networks; (2) integrated antibiotic-osteogenic growth factor/peptide frameworks; (3) mechanistically direct biofilm matrix-disrupting enzyme matrices; (4) localized hyperthermic near-infrared (NIR) photothermal therapy combined with osteogenic scaffolds; (5) intrinsic antibiotic-free antimicrobial metal ion/nanoparticle scaffolds; and (6) alternative biological agent architectures leveraging bacteriophages or probiotic biofilms. This review summarizes the advantages, limitations, clinical potential, and future research directions of each therapeutic platform.
{"title":"Dual-Therapy Resorbable Biomaterials to Eliminate Bone Infections and Biofilms.","authors":"Luiza DaMotta, Andrés J García","doi":"10.1021/acsabm.6c01493","DOIUrl":"https://doi.org/10.1021/acsabm.6c01493","url":null,"abstract":"<p><p>Orthopedic implants can become infected in hospitals requiring additional surgeries and device replacement. The pathogenesis of these device-associated bone infections is fundamentally driven by the transition of opportunistic pathogens from a free-floating planktonic state to a surface-bound, highly resilient biofilm state. Biofilms shield resident bacteria within a self-secreted extracellular polymeric substance (EPS) matrix, making them up to 1000-fold more resistant to conventional systemic antibiotics and host-immune clearance. To overcome the clinical challenges of biofilm elimination, the field of regenerative bone biointerfaces is transitioning from traditional antibiotic therapies toward multifunctional, fully resorbable, dual-therapy biomaterial platforms. These modern architectures are engineered to simultaneously clear localized infections and orchestrate host bone tissue reconstruction within a single surgical window. This review provides a comprehensive categorization and critical evaluation of six breakthrough therapeutic themes shaping next-generation orthopedic scaffolds: (1) spatiotemporally optimized dual or multiple antibiotic delivery networks; (2) integrated antibiotic-osteogenic growth factor/peptide frameworks; (3) mechanistically direct biofilm matrix-disrupting enzyme matrices; (4) localized hyperthermic near-infrared (NIR) photothermal therapy combined with osteogenic scaffolds; (5) intrinsic antibiotic-free antimicrobial metal ion/nanoparticle scaffolds; and (6) alternative biological agent architectures leveraging bacteriophages or probiotic biofilms. This review summarizes the advantages, limitations, clinical potential, and future research directions of each therapeutic platform.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149384730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liangshan Hu, Yadong Liu, You Chen, Jiajia Ma, Jing Li, Jie Liu, Donglin Cao
Traditional 2D cell lines and mouse xenograft models have limitations in recapitulating the complexity of the tumor microenvironment (TME) and dynamic interactions between tumor and immune cells, creating an urgent need for models to evaluate immunotherapies. Patient-derived organoids (PDOs), which retain key features of original tumors, offer a platform for dissecting the TME when co-cultured with peripheral blood mononuclear cells (PBMCs). However, challenges such as inter-batch variability of PBMCs and difficulties in autologous PBMC acquisition hinder their clinical translation. This study established four stably passaged colorectal cancer organoid models and developed an allogeneic PBMC-organoid co-culture platform to investigate the immune activation and cytotoxic potential of allogeneic PBMCs. Results showed that vacuolated-structured organoids are associated with the increased proportion of CD8+ T cells in PBMCs within the co-culture system. PBMCs exhibited stronger cytotoxicity against microsatellite-stable (MSS) organoids with low PD-L1 expression, while the anti-PD-1 antibody Keytruda significantly enhanced their antitumor effects on high PD-L1-expressing organoids. The allogeneic co-culture model developed here overcomes the limitations of autologous PBMC acquisition, providing an efficient and versatile proof-of-concept platform for pre-clinical screening of immunotherapeutic drugs. Distinct from prior allogeneic co-culture systems that rely on healthy donor immune cells, our platform uniquely integrates patient-derived allogeneic PBMCs with tumor organoids, providing preliminary proof-of-concept evidence that tumor-intrinsic features may influence immunotherapy responses based on tumor-intrinsic features while preserving the pathological relevance of cancer patient immune profiles.
{"title":"An Allogeneic PBMC-Organoid Co-culture Platform for Evaluating Immunotherapy Efficacy and T-Cell-Mediated Antitumor Immunity.","authors":"Liangshan Hu, Yadong Liu, You Chen, Jiajia Ma, Jing Li, Jie Liu, Donglin Cao","doi":"10.1021/acsabm.6c01270","DOIUrl":"https://doi.org/10.1021/acsabm.6c01270","url":null,"abstract":"<p><p>Traditional 2D cell lines and mouse xenograft models have limitations in recapitulating the complexity of the tumor microenvironment (TME) and dynamic interactions between tumor and immune cells, creating an urgent need for models to evaluate immunotherapies. Patient-derived organoids (PDOs), which retain key features of original tumors, offer a platform for dissecting the TME when co-cultured with peripheral blood mononuclear cells (PBMCs). However, challenges such as inter-batch variability of PBMCs and difficulties in autologous PBMC acquisition hinder their clinical translation. This study established four stably passaged colorectal cancer organoid models and developed an allogeneic PBMC-organoid co-culture platform to investigate the immune activation and cytotoxic potential of allogeneic PBMCs. Results showed that vacuolated-structured organoids are associated with the increased proportion of CD8+ T cells in PBMCs within the co-culture system. PBMCs exhibited stronger cytotoxicity against microsatellite-stable (MSS) organoids with low PD-L1 expression, while the anti-PD-1 antibody Keytruda significantly enhanced their antitumor effects on high PD-L1-expressing organoids. The allogeneic co-culture model developed here overcomes the limitations of autologous PBMC acquisition, providing an efficient and versatile proof-of-concept platform for pre-clinical screening of immunotherapeutic drugs. Distinct from prior allogeneic co-culture systems that rely on healthy donor immune cells, our platform uniquely integrates patient-derived allogeneic PBMCs with tumor organoids, providing preliminary proof-of-concept evidence that tumor-intrinsic features may influence immunotherapy responses based on tumor-intrinsic features while preserving the pathological relevance of cancer patient immune profiles.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The charm of small-molecules-based building blocks lies in their facile synthetic routes, programmable supramolecular interactions, and synergistic functions. Here, a solvent-free gel system constructed with thioctic acid (TA) and Cu(OAc)2·H2O is proposed, in which the ingredients were ground together and subsequently subjected to thermal polymerization under vacuum. Interestingly, Cu(II) ions from Cu(OAc)2·H2O were reduced to Cu(I); meanwhile, a small amount of TA was oxidized to thiosulfinate ester. The resulted gel exhibited a low swelling ratio (<5%), excellent self-healing (>95% recovery), high ductility (up to 2800% elongation), tissue adhesion (0.06-0.11 MPa), and photothermal performance (70 °C under 808 nm irradiation). Since sulfur-copper coordination could neutralize the adverse effects of Cu(I), this gel exhibited desirable biocompatibility, broad-spectrum antimicrobial activity, and low cellular toxicity. Furthermore, glutathione (GSH), an endogenous antioxidant, was incorporated into the gel network to synergistically enhance antioxidant capacity, copper valence stabilization, and tissue regeneration. Moreover, the gel promoted wound healing in an MRSA-infected diabetic open-wound model, achieving a 90% wound-healing rate within 15 days with 46% reduction in TNF-α and 142% increase in CD31 expression compared to the control. This work was themed on simple building blocks, facile gel preparation, and heavy-metal coordination-driven supramolecular polymer networks, which provided an approach toward reducing the toxicity of heavy-metal ions while utilizing the advantages of heavy-metal therapy for diseases.
{"title":"Synthesis of Solvent-Free Cu(I) Gel and Its Applications in Diabetic Wound Healing.","authors":"Zhi-Wei Huang, Ting-Ting Zheng, Lan-Ling Liu, Yi-Fan Sun, Xiao-Yu Zhang, Yue-Han Li, Xiao-Bin Zhang, He-He Jiang, Meng-Zhen Xing, Zhi-Hui Jiang, Xiao Yang, Yu-Ning Ma, Chen Chen","doi":"10.1021/acsabm.6c01406","DOIUrl":"https://doi.org/10.1021/acsabm.6c01406","url":null,"abstract":"<p><p>The charm of small-molecules-based building blocks lies in their facile synthetic routes, programmable supramolecular interactions, and synergistic functions. Here, a solvent-free gel system constructed with thioctic acid (TA) and Cu(OAc)2·H2O is proposed, in which the ingredients were ground together and subsequently subjected to thermal polymerization under vacuum. Interestingly, Cu(II) ions from Cu(OAc)2·H2O were reduced to Cu(I); meanwhile, a small amount of TA was oxidized to thiosulfinate ester. The resulted gel exhibited a low swelling ratio (<5%), excellent self-healing (>95% recovery), high ductility (up to 2800% elongation), tissue adhesion (0.06-0.11 MPa), and photothermal performance (70 °C under 808 nm irradiation). Since sulfur-copper coordination could neutralize the adverse effects of Cu(I), this gel exhibited desirable biocompatibility, broad-spectrum antimicrobial activity, and low cellular toxicity. Furthermore, glutathione (GSH), an endogenous antioxidant, was incorporated into the gel network to synergistically enhance antioxidant capacity, copper valence stabilization, and tissue regeneration. Moreover, the gel promoted wound healing in an MRSA-infected diabetic open-wound model, achieving a 90% wound-healing rate within 15 days with 46% reduction in TNF-α and 142% increase in CD31 expression compared to the control. This work was themed on simple building blocks, facile gel preparation, and heavy-metal coordination-driven supramolecular polymer networks, which provided an approach toward reducing the toxicity of heavy-metal ions while utilizing the advantages of heavy-metal therapy for diseases.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yongchen Zhao, Lu Yang, Saijiao Lan, Chun Tian, Qiongyu Guo, Chong Zhang, Decheng Wu
Corneal injuries and infections pose a serious threat to vision worldwide. Current corneal repair strategies face challenges associated with donor shortages, complex surgical procedures, and inadequate performance of existing sealants, including poor wet adhesion, excessive swelling, insufficient mechanical stability, and lack of intrinsic antibacterial activity. Herein, we developed an in situ injectable and intrinsically antibacterial hydrogel sealant (TAE) for sutureless corneal repair by integrating NHS-functionalized tetra-poly(ethylene glycol), amine-modified gelatin, and ε-polylysine. Upon delivery through a dual-barrel syringe, rapid covalent crosslinking between NHS esters and amine groups enabled fast gelation, conformal defect filling, and stable adhesion under wet physiological conditions. The optimized TAE hydrogel exhibited high optical transparency, restrained swelling behavior, strong wet-tissue adhesion, suitable mechanical properties, high burst pressure, and controlled degradation. In vitro studies demonstrated that the hydrogel supported corneal epithelial cell proliferation with favorable cytocompatibility while providing broad-spectrum antibacterial activity. In a rabbit lamellar stromal defect model, the TAE hydrogel promoted corneal regeneration by facilitating re-epithelialization, restoring transparency, and improving stromal organization while attenuating inflammatory responses and fibrosis-associated stromal remodeling compared with the untreated control group. These findings highlight TAE as a promising hydrogel sealant for sutureless corneal repair.
{"title":"Development of an Injectable Antibacterial Adhesive Sealant for Sutureless Repair of Corneal Injuries.","authors":"Yongchen Zhao, Lu Yang, Saijiao Lan, Chun Tian, Qiongyu Guo, Chong Zhang, Decheng Wu","doi":"10.1021/acsabm.6c01285","DOIUrl":"https://doi.org/10.1021/acsabm.6c01285","url":null,"abstract":"<p><p>Corneal injuries and infections pose a serious threat to vision worldwide. Current corneal repair strategies face challenges associated with donor shortages, complex surgical procedures, and inadequate performance of existing sealants, including poor wet adhesion, excessive swelling, insufficient mechanical stability, and lack of intrinsic antibacterial activity. Herein, we developed an in situ injectable and intrinsically antibacterial hydrogel sealant (TAE) for sutureless corneal repair by integrating NHS-functionalized tetra-poly(ethylene glycol), amine-modified gelatin, and ε-polylysine. Upon delivery through a dual-barrel syringe, rapid covalent crosslinking between NHS esters and amine groups enabled fast gelation, conformal defect filling, and stable adhesion under wet physiological conditions. The optimized TAE hydrogel exhibited high optical transparency, restrained swelling behavior, strong wet-tissue adhesion, suitable mechanical properties, high burst pressure, and controlled degradation. In vitro studies demonstrated that the hydrogel supported corneal epithelial cell proliferation with favorable cytocompatibility while providing broad-spectrum antibacterial activity. In a rabbit lamellar stromal defect model, the TAE hydrogel promoted corneal regeneration by facilitating re-epithelialization, restoring transparency, and improving stromal organization while attenuating inflammatory responses and fibrosis-associated stromal remodeling compared with the untreated control group. These findings highlight TAE as a promising hydrogel sealant for sutureless corneal repair.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149384729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In native bone, the transition from dense cortical bone to porous cancellous bone reflects a spatial coordination between mechanical support and mass transport. Inspired by this structural heterogeneity, this study proposes an OsteoFlux (OF) scaffold featuring a radially graded TPMS structure together with a corresponding 3D printing strategy. Specifically, a biomimetic TPMS scaffold design integrating a continuous pore-size gradient with an explicit gradient position constraint was developed. Fluid-structure interaction (FSI) simulations investigating the effects of TPMS topology and gradient parameters on scaffold mechanical and transport performance were performed. The results indicated that the OF scaffold (a Gyroid (G-type) scaffold with an 800-400 μm radial pore-size gradient) achieved the most favorable combination of mechanical stability and fluid transport performance. Finally, an experiment optimizing the BCP slurry system and digital light processing (DLP) printing parameters was conducted. The fabricated OF scaffold exhibited a compressive strength of 3.25 MPa, a compressive modulus of 172.55 MPa, and a permeability of 4.17 × 10-9 m2. In vitro biological evaluation demonstrated favorable cytocompatibility, along with enhanced osteogenic differentiation and matrix mineralization of mBMSCs under scaffold-conditioned culture conditions. These findings demonstrate that the proposed OF scaffold provides an effective strategy for enhancing the overall performance of porous ceramic scaffolds.
{"title":"3D-Printed OsteoFlux Scaffolds with Radially Graded TPMS Structures.","authors":"Miaomiao Zheng, Shiquan Shen, Yutong Chen, Shun Zhang, Jian Chao, Yan Xu","doi":"10.1021/acsabm.6c01507","DOIUrl":"https://doi.org/10.1021/acsabm.6c01507","url":null,"abstract":"<p><p>In native bone, the transition from dense cortical bone to porous cancellous bone reflects a spatial coordination between mechanical support and mass transport. Inspired by this structural heterogeneity, this study proposes an OsteoFlux (OF) scaffold featuring a radially graded TPMS structure together with a corresponding 3D printing strategy. Specifically, a biomimetic TPMS scaffold design integrating a continuous pore-size gradient with an explicit gradient position constraint was developed. Fluid-structure interaction (FSI) simulations investigating the effects of TPMS topology and gradient parameters on scaffold mechanical and transport performance were performed. The results indicated that the OF scaffold (a Gyroid (G-type) scaffold with an 800-400 μm radial pore-size gradient) achieved the most favorable combination of mechanical stability and fluid transport performance. Finally, an experiment optimizing the BCP slurry system and digital light processing (DLP) printing parameters was conducted. The fabricated OF scaffold exhibited a compressive strength of 3.25 MPa, a compressive modulus of 172.55 MPa, and a permeability of 4.17 × 10-9 m2. In vitro biological evaluation demonstrated favorable cytocompatibility, along with enhanced osteogenic differentiation and matrix mineralization of mBMSCs under scaffold-conditioned culture conditions. These findings demonstrate that the proposed OF scaffold provides an effective strategy for enhancing the overall performance of porous ceramic scaffolds.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jing Zhou, Shanshan Pang, Li Qin, Rong Xu, Hongtai Shi, Jianhe Gan
With growing incidence and limited treatment modalities, drug-induced liver injury (DILI) has become a prominent unmet clinical challenge. Despite being the primary clinical hepatoprotective agent, N-acetylcysteine (NAC) is severely constrained by its insufficient therapeutic efficacy and lack of liver-targeting specificity. Herein, we present the development of liver-targeted carbon dots (HTGN-CDs) as a precision nanotherapeutic against DILI. On the one hand, GN-CDs were synthesized using NAC and glucose as precursors, with NAC incorporation significantly strengthening the antioxidative capacity of CDs. On the other hand, surface functionalization with glycyrrhetinic acid-polyethylene glycol (GA-PEG) endowed the GN-CDs with enhanced hepatocyte-targeting capability, thereby promoting their accumulation in the liver. In vitro assays confirmed the potent antioxidant and anti-inflammatory activity of GN-CDs, while in vivo studies in acetaminophen (APAP)-overdose mice demonstrated that HTGN-CDs significantly reduced hepatocyte necrosis and lowered key biochemical indicator levels, with efficacy superior to the clinical standard NAC. Mechanistically, HTGN-CDs mitigated oxidative stress via the restoration of antioxidant enzyme activity and suppressed inflammation by blocking pro-inflammatory cytokine release and macrophage infiltration. Safety assessments verified excellent biocompatibility of HTGN-CDs, with no detectable hemolytic activity, hematological abnormalities, or organ toxicity observed. Collectively, our findings highlight HTGN-CDs as a promising multifunctional nanotherapeutic for DILI, with substantial potential for clinical translation.
{"title":"Engineering Liver-Targeted Carbon Dots for Hepatic Injury Therapy.","authors":"Jing Zhou, Shanshan Pang, Li Qin, Rong Xu, Hongtai Shi, Jianhe Gan","doi":"10.1021/acsabm.6c01232","DOIUrl":"https://doi.org/10.1021/acsabm.6c01232","url":null,"abstract":"<p><p>With growing incidence and limited treatment modalities, drug-induced liver injury (DILI) has become a prominent unmet clinical challenge. Despite being the primary clinical hepatoprotective agent, N-acetylcysteine (NAC) is severely constrained by its insufficient therapeutic efficacy and lack of liver-targeting specificity. Herein, we present the development of liver-targeted carbon dots (HTGN-CDs) as a precision nanotherapeutic against DILI. On the one hand, GN-CDs were synthesized using NAC and glucose as precursors, with NAC incorporation significantly strengthening the antioxidative capacity of CDs. On the other hand, surface functionalization with glycyrrhetinic acid-polyethylene glycol (GA-PEG) endowed the GN-CDs with enhanced hepatocyte-targeting capability, thereby promoting their accumulation in the liver. In vitro assays confirmed the potent antioxidant and anti-inflammatory activity of GN-CDs, while in vivo studies in acetaminophen (APAP)-overdose mice demonstrated that HTGN-CDs significantly reduced hepatocyte necrosis and lowered key biochemical indicator levels, with efficacy superior to the clinical standard NAC. Mechanistically, HTGN-CDs mitigated oxidative stress via the restoration of antioxidant enzyme activity and suppressed inflammation by blocking pro-inflammatory cytokine release and macrophage infiltration. Safety assessments verified excellent biocompatibility of HTGN-CDs, with no detectable hemolytic activity, hematological abnormalities, or organ toxicity observed. Collectively, our findings highlight HTGN-CDs as a promising multifunctional nanotherapeutic for DILI, with substantial potential for clinical translation.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Otavio Augusto Silva, Fernanda Reis Veregue, Ariane Regina de Souza Rossin, Antônia Millena de Oliveira Lima, Heveline Dal Magro Follmann, Roberta Maia Sabino, Rafael Silva, Paulo Ricardo de Souza, Alessandro Francisco Martins
This study describes the preparation and characterization of keratin-based polyelectrolyte multilayers (PEMs) deposited on oxidized polystyrene (PSox) using the layer-by-layer technique. Supernatant keratin (SK), precipitate keratin (PK), and N,N,N-trimethyl chitosan (TMC) were used as polyelectrolytes to assemble PMEs with 6 and 14 layers, respectively. Atomic force microscopy, water contact angle (WCA), and X-ray photoelectron spectroscopy analyses confirmed the formation of PEMs on PSox. PEM's surface composition and morphology depended on both the keratin fraction (SK and PK) and the number of deposited layers (6 or 14). The resulting PEMs exhibited WCA between 31°-41° and root-mean-square surface roughness of 8-18 nm. The PMEs also remained on the substrate after 24 h of exposure to phosphate-buffered saline (PBS, pH 7.4). Antibacterial assays against Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa) showed reduced bacterial adhesion and increased bacterial inactivation on the coated PSox. Among the evaluated systems, the 14-layer PEMs made of SK and TMC (SK/TMC)14 exhibited the highest antimicrobial activity against S. aureus, achieving 51% area coverage of dead, adhered cells after 24 h of incubation. No cytotoxic effects toward adipose-derived stem cells (ADSCs) were detected for PMEs based on SK/TMC and PK/TMC. Overall, the results show that keratin/TMC-based PEMs reduce bacterial colonization while maintaining cytocompatibility with mammalian cells, supporting their use as surface coatings for biomedical purposes.
{"title":"Cytocompatible and Antimicrobial Human Hair-Derived Keratin/N,N,N-Trimethyl Chitosan Polyelectrolyte Multilayers.","authors":"Otavio Augusto Silva, Fernanda Reis Veregue, Ariane Regina de Souza Rossin, Antônia Millena de Oliveira Lima, Heveline Dal Magro Follmann, Roberta Maia Sabino, Rafael Silva, Paulo Ricardo de Souza, Alessandro Francisco Martins","doi":"10.1021/acsabm.6c01368","DOIUrl":"https://doi.org/10.1021/acsabm.6c01368","url":null,"abstract":"<p><p>This study describes the preparation and characterization of keratin-based polyelectrolyte multilayers (PEMs) deposited on oxidized polystyrene (PSox) using the layer-by-layer technique. Supernatant keratin (SK), precipitate keratin (PK), and N,N,N-trimethyl chitosan (TMC) were used as polyelectrolytes to assemble PMEs with 6 and 14 layers, respectively. Atomic force microscopy, water contact angle (WCA), and X-ray photoelectron spectroscopy analyses confirmed the formation of PEMs on PSox. PEM's surface composition and morphology depended on both the keratin fraction (SK and PK) and the number of deposited layers (6 or 14). The resulting PEMs exhibited WCA between 31°-41° and root-mean-square surface roughness of 8-18 nm. The PMEs also remained on the substrate after 24 h of exposure to phosphate-buffered saline (PBS, pH 7.4). Antibacterial assays against Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa) showed reduced bacterial adhesion and increased bacterial inactivation on the coated PSox. Among the evaluated systems, the 14-layer PEMs made of SK and TMC (SK/TMC)14 exhibited the highest antimicrobial activity against S. aureus, achieving 51% area coverage of dead, adhered cells after 24 h of incubation. No cytotoxic effects toward adipose-derived stem cells (ADSCs) were detected for PMEs based on SK/TMC and PK/TMC. Overall, the results show that keratin/TMC-based PEMs reduce bacterial colonization while maintaining cytocompatibility with mammalian cells, supporting their use as surface coatings for biomedical purposes.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fatiha Farhana, Guanyu Chen, Rebecca L Stratton, Bishal Pokhrel, Adeola Adeyemi, Songping D Huang, Hao Shen
Antimicrobial resistance (AMR) represents a worsening global health emergency, with projections estimating more than 39 million deaths attributable to drug-resistant bacteria by 2050. Diabetic patients face a compounded threat: chronic hyperglycemia suppresses host immunity while enriching wound microenvironments with glucose, accelerating methicillin-resistant Staphylococcus aureus (MRSA) proliferation and rendering conventional antibiotics increasingly ineffective. Here, we report a minimalist, enzyme-free antibacterial strategy based on citrate-stabilized 30 nm gold nanoparticles (AuNPs) that exploit this glucose surplus as a catalytic substrate. Through intrinsic glucose oxidase- and peroxidase-like dual activities, these AuNPs convert ambient glucose and oxygen into a localized cascade of bactericidal reactive oxygen species (ROS), achieving >90% growth inhibition against both methicillin-susceptible S. aureus (MSSA) and MRSA USA300 at concentrations as low as 12.5 pM. Scavenger experiments establish oxidative membrane damage as the primary killing mechanism, and SEM and TEM analyses confirm that AuNPs preferentially accumulate at the bacterial cell membrane, confining ROS production to the site of maximum biological vulnerability. This membrane-localized catalysis, further amplified by brief 532 nm irradiation, accounts for the marked superiority of spherical AuNPs over gold nanorods of comparable composition, demonstrating that spatial localization rather than bulk ROS output governs the killing efficiency. This glucose-fueled, antibiotic-free platform offers a rational strategy for treating drug-resistant infections in hyperglycemic wound environments.
{"title":"Glucose-Fueled Gold Nanozymes Achieve Picomolar Eradication of Drug-Resistant Staphylococcus aureus.","authors":"Fatiha Farhana, Guanyu Chen, Rebecca L Stratton, Bishal Pokhrel, Adeola Adeyemi, Songping D Huang, Hao Shen","doi":"10.1021/acsabm.6c01114","DOIUrl":"https://doi.org/10.1021/acsabm.6c01114","url":null,"abstract":"<p><p>Antimicrobial resistance (AMR) represents a worsening global health emergency, with projections estimating more than 39 million deaths attributable to drug-resistant bacteria by 2050. Diabetic patients face a compounded threat: chronic hyperglycemia suppresses host immunity while enriching wound microenvironments with glucose, accelerating methicillin-resistant Staphylococcus aureus (MRSA) proliferation and rendering conventional antibiotics increasingly ineffective. Here, we report a minimalist, enzyme-free antibacterial strategy based on citrate-stabilized 30 nm gold nanoparticles (AuNPs) that exploit this glucose surplus as a catalytic substrate. Through intrinsic glucose oxidase- and peroxidase-like dual activities, these AuNPs convert ambient glucose and oxygen into a localized cascade of bactericidal reactive oxygen species (ROS), achieving >90% growth inhibition against both methicillin-susceptible S. aureus (MSSA) and MRSA USA300 at concentrations as low as 12.5 pM. Scavenger experiments establish oxidative membrane damage as the primary killing mechanism, and SEM and TEM analyses confirm that AuNPs preferentially accumulate at the bacterial cell membrane, confining ROS production to the site of maximum biological vulnerability. This membrane-localized catalysis, further amplified by brief 532 nm irradiation, accounts for the marked superiority of spherical AuNPs over gold nanorods of comparable composition, demonstrating that spatial localization rather than bulk ROS output governs the killing efficiency. This glucose-fueled, antibiotic-free platform offers a rational strategy for treating drug-resistant infections in hyperglycemic wound environments.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}